search

Active clinical trials for "Heart Diseases"

Results 1911-1920 of 3529

Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes

Heart DiseasesCardiac Arrhythmias3 more

Frequent monomorphic premature ventricular complexes (PVCs) may cause a cardiomyopathy (CMP) that is reversible by suppression of the ectopic focus. This study investigates whether PVC suppression therapy can improve cardiac function and clinical condition of patients with idiopathic or ischemic CMP and frequent monomorphic PVCs. For this purpose, patients will be randomized to either one of two treatment strategies: 1) conventional heart failure therapy plus PVC suppression therapy, consisting of RFCA as primary treatment and Amiodarone as secondary treatment in case of unsuccessful RFCA, or 2) conventional heart failure therapy without PVC suppression therapy.

Unknown status20 enrollment criteria

Cost-effectiveness of Outpatient Versus Hospital Cardiac Rehabilitation

Coronary Heart Disease

The hypothesis is that home based clinical rehabilitation (CR) is less expensive than hospital based CR with similar clinical effectiveness. The investigators will compare the results of two forms of CR on direct and indirect healthcare costs effectiveness on mortality, morbidity, modifiable risk factors control, functional capacity measured by exercise testing, health related quality of life and satisfaction rate cost/effectiveness analysis

Unknown status4 enrollment criteria

The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting

Ischemic Heart Disease

The superiority of a percutaneous coronary intervention (PCI) by one stent over another in terms of clinical outcome is usually documented in large randomized controlled trials (RCT). Although generated from selected study populations these data form the basis for evidence based practice (EBP) in the entire population of patients considered for coronary intervention. An inherent limitation of this approach is that study populations differ significantly from all comers in terms of patient characteristics and prognosis undermining the foundation for extrapolation of trial results to all comers. Furthermore, other trials are based on a "one-fits-all" concept, while the benefits of an "individual-tailored" approach that might be superior, is not investigated. The Purpose of the current study is to Compare clinical outcome between several CE marked drug eluting stents Compare clinical outcome between several CE marked bare metal stents Compare clinical outcome in all comers with that of the selected study population of RCT's Evolve methods to compare clinical outcomes between the generalized "one-fits-all" versus the individualized or "individual-tailored" stent selection approaches The Method employed is All comer PCI registry - single centre Randomisation of all eligible patients within the registry to one of several study stent Quality assurance in non-randomized population within the registry by periodical alternating the institutional standard stent Continuous follow up of all patients included the registry by means of systematic event detection and classification by an independent safety and end point committee Assessment of effects on quality of life by heart and health questionnaires Outcome Measures Primary endpoints: Composite of cardiac death, acute myocardial infraction and target vessel revascularisation Stent thrombosis A specifically developed Treatment Failure Rate classification Secondary outcome measures include each of the above, target lesion revascularisation and total death analyzed in a hierarchical fashion at 2, 3, 4 and 5 years. Tertiary outcome measure is self reported quality of life based on health questionnaires on general health and cardiac symptoms. Power Calculations An event rate of 20% within 5 years, a relative difference of 25% (an absolute difference of 5%), P< 5%, Power > 80% => 900 patients in each of two treatment arms. Prespecified Analysis include The MACE rates between stent types The Stent thrombosis rates between stent types The Treatment failure rates between stent types The randomized population versus non-randomized population The individualized versus the generalized Population QOL between stent types

Unknown status5 enrollment criteria

Study of Enahnced External Counterpulsation to Treat Coronary Heart Disease

Coronary Artery Disease

To investigate the mid- and long-term effect of Enhanced External Counterpulsation combined with guideline-driven standard treatment on patients documented with and/or at high risk of coronary artery disease.

Unknown status13 enrollment criteria

Clinical Study of Hypoxia-Stressed Bone Marrow Mononuclear Cell Transplantation to Treat Heart Diseases...

Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)

The purpose of this study, is to determine the differences of clinical outcomes between hypoxic pre-treatment group and control group in bone marrow stem cell transplantation (BM-SCT) to treat acute myocardial infarction (AMI); and to evaluate the safety of both treatments. Heart failure patients underwent PCI treatment after AMI and with informed consent, are randomized allocation into hypoxic pre-treated BM-SCT group, normoxic pre-treated BM-SCT group, and control group. Cell resuspension is intracoronary injected into patients receiving coronary angiography, IL-6, CRP, TNF and BNP are detected; echocardiography, cardiac MRI and ECT are analyzed to evaluate heart function and alive myocardial cells. Holter's ECG monitor is employed to observe arrhythmia and embolism. We hypothesize that, by receiving hypoxic pre-treated BM-SCT, impaired heart function will be reversed in heart failure patients.

Unknown status8 enrollment criteria

Video-Assisted Left Atrial Appendage Exclusion Trial

Heart Diseases

Exclusion of the LAA(Left Atrial Appendage) using the TigerPaw II System with VATS technique is safe and effective.

Withdrawn33 enrollment criteria

A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left...

Pulmonary Hypertension

Right ventricular (RV) failure is the leading cause of death in pulmonary arterial hypertension. (PAH) Right ventricular ejection fraction is one of the most important predictors of prognosis in heart failure patients regardless of cause. It is estimated that 30-50% of patients with heart failure and preserved ejection fraction (HFpEF) have right ventricular dysfunction and up to 70% of these patients will have significant pulmonary hypertension (PH), both of which are related to much worse prognosis. Right ventricular failure is becoming an increasingly prevalent and significant cause of morbidity in patients with left heart disease. Despite the significance of RV function to survival, there are no therapies available that directly or selectively improve RV function. The overall theme of this research project is to evaluate the mechanisms that contribute to the cause of right heart failure. This small study is designed to look at the role of heart and lung metabolism and pulmonary hypertension as they relate to the development of right heart failure in cardiovascular disease.(PH-LHD)

Terminated9 enrollment criteria

Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants

Congenital Heart Disease

The goal of this study is to evaluate specific hormone levels in children undergoing heart surgery in order to identify patterns associated with any unstable vital signs. The data collected will provide preliminary answers to the question "Are hormone values a determining factor for drug administration and dosing levels?" and help establish the benefits of routine steroid and hormone administration. Sixty subjects will be enrolled. Blood samples will be drawn before the surgery,and again nine hours after surgery for analysis. Other patient data such as medications, vital signs, routine lab values and treatments will also be analyzed. As our current standard of care includes routine doses of steroids, we believe this study will increase our general knowledge and improve the care of these critically ill children. The study will also provide the foundation needed for grant support from the American Heart Association, allowing for future larger scale studies.

Terminated12 enrollment criteria

Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes...

Cardiovascular DiseasesCoronary Disease2 more

The purpose of this study is to compare 5-year mortality rates in diabetic individuals with multivessel coronary artery disease (CAD) who undergo either coronary artery bypass grafting (CABG) surgery or percutaneous coronary stenting.

Unknown status27 enrollment criteria

Best Bypass Surgery (BBS) Trial

Heart DiseaseCardiovascular Disease

There is evidence linking cardiopulmonary bypass to negative side effects when used for coronary artery bypass grafting. Coronary artery bypass grafting can be performed without the use of cardiopulmonary bypass. The purpose of this study is to determine the positive and negative effects of coronary artery bypass grafting with or without the use of cardiopulmonary bypass. The patients will be followed at least one year after surgery.

Unknown status9 enrollment criteria
1...191192193...353

Need Help? Contact our team!


We'll reach out to this number within 24 hrs